Pune, India, Sept. 19, 2022 (GLOBE NEWSWIRE) — The global Digital Pathology Market The size was estimated at $798.8 million in 2021 and reached $892.5 million in 2022. The market is expected to reach USD 2,045.9 million by 2029, registering a CAGR of 12.6% over the forecast period. Increasing awareness of novel diagnostics and increasing prevalence of chronic diseases are expected to boost market growth. Fortune Business Insights™ shares this information in its report titled Digital Pathology Market, 2022-2029.
key industry development
- March 2022 – Thermo Fisher Scientific, Inc. released the CE-IVD marked Ion Torrent Genexus Dx Integrated Sequencer, an automated next-generation sequencing (NGS) platform for use in clinical laboratories and for conducting diagnostic and clinical research.
- April 2022- 3DHISTECH Ltd. concluded an agreement with the Catalan Health Institute (ICS). This strategy was followed for the deployment of digital tools for pathology in a network of 8 hospitals.
Get a PDF sample brochure: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/digital-pathology-market-100229
report coverage
The report provides a detailed analysis of the top segments and the latest trends in the market. It comprehensively discusses the driving and restraining factors and the impact of COVID-19 on the market. In addition, the regional developments and the strategies of the key market players are examined.
Report scope:
| report coverage | details |
| forecast period | 2022 to 2029 |
| Forecast period 2022 to 2029 CAGR | 12.6% |
| Value prognosis 2029 | 2,045.9 million |
| base year | 2021 |
| Market size in 2022 | $892.5 million |
| Historical data for | 2018 to 2020 |
| number of pages | 149 |
Driving Factors
Strong approvals for digital tools can boost market growth
Digital pathology is a digital tool that collects, analyzes and interprets pathological information. Increasing approvals for digital tools may boost product demand. Increasing chronic diseases and an exponential approach…
